Aug 16, 2024 / 07:00AM GMT
Kari Krogstad - Medistim ASA - President, Chief Executive Officer
So a very good morning from Medistim headquarter in Oslo, and we are welcoming everyone on this Friday, the August 16, to the second quarter and first half 2024 financial results. My name is Kari Krogstad, and together with CFO, Thomas Jakobsen. We are going to take you through the highlights of the quarter and the first half, then we'll go through the financial statements, provide more comments into the various business segments and then wrap up with reiterating our strategy.
So Medistim goal and ambition has been and still is to deliver profitable growth consistently over time. And our track record shows that we have succeeded to deliver on this promise over the years with sales growth around 10%.
We aim to deliver growth every single quarter. But as you saw in the fourth quarter last year, this is not always possible. So in the first quarter, we came back with a growth of 3.5%. And this second quarter we continued the improvement.
So for the second quarter, we did delivering a revenue of almost NOK145 million.
Q2 2024 Medistim ASA Earnings Call Transcript
Aug 16, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers